Chargement en cours...
OTME-18. Targeted CRISPR/Cas9 gene-editing regulates the brain tumor environment
Glioblastoma multiform (GBM) is the most common malignant brain tumor. Recent immunotherapy has demonstrated potential to treat GBM. However, the immune suppressive tumor environment in the brain represents a significant barrier for the treatment of GBM. Overexpression of programmed death ligand-1 (...
Enregistré dans:
| Publié dans: | Neurooncol Adv |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8255424/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab070.069 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|